Be The Match BioTherapies® and Vineti announced a collaboration to create streamlined solutions that alleviate supply chain management difficulties related to cell and gene therapies. The collaboration is non-exclusive and is expected to unite the industry’s top workflow programs: Vineti’s Personalized Therapy Management® platform and Be The Match BioTherapies’ cellular therapy supply chain management services.
Vineti offers a commercial cloud-based platform to make it easier for patients to access life-saving gene and cell therapies. Be The Match BioTherapies is known for its unique customizable cell and gene therapy solutions which support the end-to-end cell therapy supply chain. With support from the National Marrow Donor Program and the Center for International Blood and Marrow Transplant Research, the company is working to accelerate patient access to life-saving gene and cell therapies.
The shared goal of saving lives through access to gene and cell therapies is what brought this collaboration to be. Amy Romenberg, CEO of Be The Match Biotherapies and the National Marrow Donor Program, described the importance of the collaboration. She said, “This is a message to the industry that both parties are committed to improving our clients’ experience, and to improving outcomes for patients by building a combined solution that eliminates unnecessary complexity.”
The two plan to take full advantage of their collaboration, combining each team’s knowledge to innovate and build solutions that mix Be The Match Biotherapies’ best supply chain practices with Vineti’s consistent understanding of therapy management and digital tech. They plan to expand therapy management, digitized compliance for cell and gene therapies, and automated traceability.
Read the full article here.